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Sebaceous glands were isolated by manual dissection under a 
microscope from surgical specimens of scalp skin with male 
pattern baldness and skin specimens of hairy and bald seal", 
obtained at autopsy. The 800 X g pellet (nuclear fraction) 
and the 164,000 X g supernatant fraction (cytosol) of ho-
rnogenatcs of the sebaceous glands were used for measure-
ments of androgen binding characteristics. using dextran-
coated charcoal and sucrose gradient methods. Scatchard 
plots showed high affinity binding for ['H]dihydrotestoster-
one (DHT) and ['HJmethyltrienolone (R1881). Nuclei pre-
pared from bald scalp contained greater total androgen bind-
ing capacity than nuclei ofhaity scalp, although Kd values of 
rype [ binding were similar (0.68 vs 0.56 nM, respectively). 
On sucrose gradient, the binding protein from cytosol was 
found in the 7 to 85 density range. Androgen binding by 
cytosol of sebaceous glands of hairy scalp had Kd of 1.89 ± 
T he developmenc of secondary sex characteristics in the skin is regulated by sex hormones [t -3] and the an-drogens especially have profound influences on cellu-lar activities of the skin [2,3]. Action of steroids in skin is assumed to be mediated as in other target organs, by 
intracellular receprors, which bind the specific steroid. and after a 
temperature-dependent translocation of rhe receptor-steroid com-
plex inro the nucleus of the cell. the steroid binds to a specific DNA 
segment to affect genetic expression. Recent studies indicate that 
steroid receptors may be intranuclear [4,5] and nuclear binding of 
steroids especially deserves attention. 
Androgen action has been studied in cultured human fibroblasts 
[6,7J and whole human skin of various body sites [8,9J. It has been 
observed that the androgen binding capacity of skin varies with 
anatomical sites and other conditions, but detailed information on 
the molecular events of androgen action in the skin is lacking. 
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Abbreviations: 
Bp: bald scalp specimen obtained at autopsy 
Bs: bald scalp specimen obtained at surgery 
65-3 p-hydroxysreroid dehydrogenase: 3PHSD 
DHA: dehydroepiandrosterone 
E2: estradiol 
H: hairy scalp 
R 1881 : 17a-mcthyltricnolone 
R2858: moxestrol 
R5020: promegesrone 
. 79 and 2.05 ± .56 nM for DHT and R1881, respectively, 
and Bmax of18.7 ± 4.4 and 20.0 ± 4.6 fmol/mg protein for 
D HT and R I88l, respectively. Cytosol from sebaceous 
glands of bald scalp had Kd values approximately half those 
of hairy scalp, and Bmax values 50%-100% higher. The 
bound 'H labeled DHT and R 1881 could be partially dis-
placed by testosterone (40-50%), Illoxestrol (28-32%), 
promegestone (19-26%), and d'-androstenedione (6-
12%), but not by dehydroepiandrosterone. These data dem-
onstrate the presence of specific androgen binding protein in 
sebaceous glands, and that sebaceous glands of bald scalp have 
greater binding affinity and capacity for androgens than 
those in hairy scalp. This difference may explain the greater 
androgenic response in androgenic alopecia.) Invesl Dermatol 
92:91-95,1988 
Because the sebaceous gland is especially sensitive to androgenic 
stimulation, a detailed study of androgen action in the sebaceous 
gland is desirable. In this paper we report a study of androgen bind-
ing properties of human sebaceous glands isolated by a microdissec-
tion procedure. We found greater androgen binding capacity in the 
cytosol and nuclei of sebaceous glands isoi3ted from bald scalp of 
patients with androgenic alopecia than glands isolated from hairy 
scalp. 
MATERIALS AND METHODS 
Chemicals [1.2-'HJ5Q-dihydrotestosterone (['HJDHT, 55 Ci/ 
11111101), [17Ct-methyl-'HJmethyltricnolone, (['HJRI88I, 86 Ci/ 
nunol), [I,2-'HJ-testosterone (60 Ci/mmol), P,2-lHJdehydro-
criandrosterone (['HJDHA, 55 Ci/mmol), ['HJpromegestone 
(['HJR5020, 87 Cijmmol), moxestrol ([lHJR2858, 87 Cijmmol), 
and nonradioactive R 1881, R5020 and R2858 were purchased from 
Dupont New England Nuclear (Boston, MA). Nonradioactive 
DHT, testosrerone, androstenedione, and DHA were purchased 
from Sigma Chemical Co. (St. Louis, MO). Both radiolabded and 
unlabeled steroids were purified by thin layer chromatography be-
fore use. 
Scalp Specimens Specimens of bald scalp were collected from 
men with male pattern baldness (age 25 - 39 years) undergoing hair 
transplant or scalp reduction surgery. Specimens were also collected 
from hairy and bald scalp of adult male trauma victims (30-47 
years) at auropsy within 3 h post-mortem. The specimens were put 
on ice and transported to the laboratory. Subcutaneous fat and the 
lower portions of dermis were trimmed off. The remaining skin 
specimens were cut into 3-mm pieces and soaked in Hank's buffered 
saltsolution (HBSS) containing 25 mM HEPES, pH 7.4, at 4'C for 
20-60 min. Dissection was performed under a stereomicroscope, 
using Dumont stainless sred tweezers (Nos. 5 and 55) and dispos-
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able scalpels, Scalp plugs excised from the recipient sites during hair 
transplam were treated in the same manner. Ahout I g of skin or 
13- 15 scalp plugs were used in each experiment and the dissection 
required 2 to 3 h for completion. 
Prepa ratio n of Cytosol The isolated sebaceous glands were ho-
mogenized in 10 mM Tris-HCI, pH 7.4 buffer, containing 1 mM 
EDTA, 1 mM dithiothreitol (TED buffer), and 10 111M sodium 
molybdate. with a Ten Broeck (glass to glass) tissue homogenizer. 
Cytosol was prepared by ultracentrifugation of the homogenate at 
164,000 X g for I hat 2 ·C in a Beckman L5-65B Ultracentrifuge, 
with SW 50. I swinging buckct rotor in 5 ml centrifuge tubcs 
(Beckman Instruments, Inc .• Spin co Div., Palo Alto, CA). Superna-
tant was removed with a Pasteur pipette. and the floating lipid layer 
was carefully avoided. 
This cyrosol preparation was diluted to 2 mg protein per mi. as 
determined by the Lowry method [lOJ. Aliquots (200 Ill) of the 
diluted cytosol were incubated at O°C for 30 min with 50 JlI of 
radiolabeled steroid in the presence or absence of 1.6 JlM nonra-
dioactive steroid (200 times greater than the concentration of the 
radioactive ligand). Labeled ligand in final concentrations ranging 
from 0,25 to 8 nM, was added to make up 300,u1. The incubation 
was carried out for 16- 20 h at 2-4 DC. The incubation mixture was 
then treated with dextran coated charcoal suspension [t 1] (DCC; 
0.25% Norit A, 0.0025% dextran Grade C, in 0.01 M Tris, pH 8.0), 
and centrifuged at 1600 X g for 10 min at 2°e to sediment the 
charcoal with adsorbed unbound neroid. according to Mowszowicz 
and Wright I 12]. Radioactivity was assayed in a Packard Tricarb 
liquid scintillation counter with tritium countin& efficiency of 
35%. Data were analyzed according to Scatchard [131. after subtrac-
tion of the nonspecific binding in the samples containing 200-fold 
excess of nonradioactive steroid. 
Preparation of Nuclear Fractio n For the preparation of nuclei, 
the dissected sebaceous glands were homogenized in five volumes 
of 10 111M Tris-HCI with I mM EDTA, pH 7.4, in a Ten Ilroeck 
homogenizer. The homogenate was filtered through 3 layers of 
cheesecloth and centrifuged for 20 min at 800 X g to obtain the 
nuclear peller which was washed 3 times with buffer and resedi-
memed :u 800 X g for 15 min, to break up fine aggregates and 
reduce non-specific binding. The washed nuclei were suspended in 
the same buffer. and the DNA content of the suspension was deter-
mined according to the method of Burton 114]. Examination under 
an inverted phase COntrast microscope revealed intact nuclei free of 
particulate contaminations. Tests for the nuclear marker enzyme. 5' 
nucleotidase were positive. 
Sucrose Density G radient Analysis Sucrose densiry gradients 
were prepared by layering five sucrose solutions (5, 10, 15,20, and 
25%. wjv) in TED buffer in cellulose nitrate tubes and allowing 
diffusion for 2 II at 4 DC, before application of cytosol samples to the 
top (i5J. 
Cytosol samples were prc-incubated widl 20 nM lH-laheled lig-
and with or without 200-fold excess (4 JiM) nonradioactive ligand 
for 4 hat ODC, and unbound ligand was removed by mixing 240 It! 
of the incubation mixture with a pellet of Dee (obtained from 
centrifugation of 1 cc of Dec suspension). The mixture was centri-
fuged at 1600 X g for 10 min at 2°C to sediment the charcoal-ad-
sorbed free JH-ligand. Then 200,111 of incubation mixture was care-
fully pipetted and layered on top of the 5 ml (5-25%) sucrose 
gradient and centrifuged in a Beckman SW 50.1 rotor for IB h at 
190,000 X g at o·c. Paralld gradients contained catalase (11.2S) 
and human hemoglobin (4.55) as colored external marker proteins. 
The gradients were fractionated by puncturing the bottom of the 
tube. and collected in 0.2ml fractions. Radioactivity in each fraction 
was plotted versus fraction number and the amount of specific 
bound nereid was expressed in fmol/mg protein. 
Assay for Nuclear Androgen Binding AliqllOtS of250,ul of the 
nuclear suspension were incubated with lH-methyltrienolone 
(0.4 - 12 nM) for 30 min at 37°C for androgen binding. S:auration 
analysis for total nuclear type 1 receptor sites was performed as 
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previously described [16, 17J by resuspending the nuclear pellet with 
buffer (IO mM Tris-HCI, I mM EDTA, I mM orr, 10 mM Na 
Molybdate, pH 7.4). Parallel incubation tubes contained 200-fold 
excess unlabeled ligand to dcterminl" non-specific binding. 
Qu:mtitation of nuclear type II receptor sites was examined by 
incubating the nuclei with the radioactive ligand at concentrations 
of 10-30 nM, and with panllcl tubes of «300 times unlabeled 
hormone for 30 min (37·C) in buffer of 10 mM Tris-HCI, with I 
mM EDT A (pH 7.4). 
The incubation was terminated by the addition ofl ml of ice cold 
buffer. and the mixture was then centrifuged at BOO X g for 10 min. 
The supernatant was decanted, and rhe nuclear pelle ts washed twice 
in buffer before addition of 1 rnl of ethanol for ex traction of radioac-
tivity, The tubes were rhen placed in a water barh at 30 De for 30 
min. vortexed. then centrifuged at 800 X g for to min. The total 
ethanol extract was radioassayed. Results were expressed as fmoles 
of bound ligand/mg DNA. 
RESULTS 
Ste r o id Binding b y Cytosols Binding of['H]DHT and the syn-
thetic ligand ]'HJrnethyltrienolonc (RI881) was demonstrated by 
incubation with cytosols of sebaceous glands obtained from speci-
mens of hairy scalp (H), or bald scalp obtained at autopsy (Bp) or 
surgery (Bs). Figure I shows a Scatchard plot of data obtained from 
]'HJ R 1881. The results show typical sP."cific binding of the steroid. 
An analysis of data from a study with IlHJD HT gave similar linear 
graphs (data not shown). The dissociation constant (Kd) and bind-
ing capaciry (Bmax) for the rwo androgens esrimated from these 
plors 3re shown in Table r. For cytosol of the sebaceous glands the 
Kd values were I.B9 and 2.05 nM for DHT and R IBBI. respec-
tively. For Bs and Dp glands, the values were approximately half, 
Umax va lues were 20.0 and 18.7 fmol/mg protein for DHT and 
RI88 1, respectively, for cytosol of H glands. Bmax vaJues for Bs 
and Bp glands were 35% - 70% greater. Thus, cytosol of Bs and Bp 
glands had stronger affiniry and greater binding capacity for the 
androgens than that of H glands. 
Kd and Bmax values for ]'HJpromegestone (R5020) and 
]3HJmoxestrol (R2858) are shown in Table II. When compared 
with data in Table I, these Kd values were several-fold greacer, and 
Bmax values were less than half of the values for the androgens. 
Speci6city ofcbe Binding Complex Specificity of binding was 
evaluated by displacement of ]'HJmethyltrienolone and ['H]D HT 





BOUND O moO / mil 
Figure 1. Binding ofllH]methyltrienolone by cytosol of human sebaceous 
glands analyzed by Scatchard plots. Clusl'd sqlltlftS represent sebaceous glands 
isolated from specimens of hairy sc2lp. Opm circlu represent specimens of 
bald scalp obtained 2t autopsy. Closed circlt's represent surgical specimens of 
bald scalp. 
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Table I. Comparison of Androgen Binding Properties of 




Source of Dmax flU~1j Bm2X fl110lj 
SCb2CCOUS Gl2nd Kd,nM IIlg protem Kd,nM mg protein 
H 1.89 20.0 2.05 18.7 
±.79 ±4.6 ±.56 ±4.4 
B. 0.79 34.1 0.90 30.1 
±.04 ±4.1 ±.08 ±4.3 
B, 0.95 27.0 0.90 26.8 
±.09 ±3.1 ±.30 ±3.0 
I Cytosols of 5cb2ceous gland isohteO from specimens of hairy scalp (1-1), and bald 
KOilp obtOlllleJ at ~urgery (8') or at i1UIU?,y (8 ) were incubaTed with [IHjDl-IT or PHI 
OHT or IJHlmethyltnenolone. Values and Kd and llmax were estmlate-d by the Scat· 
chard method. The \';llues are me-an ± SO of 6 samples. 
b VilluC'S of B, and B, glilnds :ue slglILhandy differed from v:llue-s of H ghnd 
(p < 0.001). 
tive steroids. Nonspecific binding, measured as that portion oPH 
nor displaced after the addition of excess nonradioactive methyl-
tricnolone, was subtracted from the measurcments. The result 
(Table 111) shows that DHT displaces arproximately 80%, while 
methylrrienolone displaces 80%-85% 0 the bound lH. Testoster-
one di'rlaces between 39%-47% of bound I'H]DHT and 47%-
52% 0 bound (lH]methyltrienolone. Androstenedione displaces 
approximately 10% of bound ['H]DHT, while no displacement 
occurred when DHA was tested. The synthctic ligands promeges-
tone and Illoxestrol displaced approximately 20% and 30% of 
bound I'H]DHT, respectively. 
Suc rose D e nsity Gradient Ana lysis The androgen receptor 
binding complexes werc furrher characterized by sucrose density 
gradient centrifugation. Cytosol samples were incubated with 20 
nM (lHJmethyltrienolone at 2°C for 4 h and subjected to sucrose 
density gradient centrifugation. A peak of radioactivity was found 
sedimenting at 7.5S (Fig 2). lH in this peak was displaceable by 
200-fold excess of non-radioactive metbyltrienolone. The csci-
mated Kd and Bmax values were in agreement with data in Table 1. 
Nuclea r Androgen R ecepto r Content Table IV shows the re-
sults of nuclear androgen receptor content in Hand B sebaceous 
glands from three separate preparations. The B glands had 20% 
higher type I receptor coment than the H glands. The type II bind-
ing data reveal nearly three times greater rccepror content in B 
(1786 fmol / mg DNA) than H glands (665 fmol / mg DNA). The 
Kd's for Band H were similar. 0.68 and 0.55 nM, forrype I binding. 
and 8.0 and 8.5 nM for t),pe II, respectively. 
DISCUSSION 
Elaborate procedures have been used in previous investigations to 
obtain sebaceous glands from human skin, requiring lengthy en-
zyme digestion [181' chemical treatment [19]. or freeze-drying of 
tissue preparations 20}. The procedure used in the present study 
Table U. Binding Properties of Sebaceous Gland Cytosolsa 
[lHJPromegestone IlH ]Moxestrol 
(R5020) (R2858) 
Source of Bmax fmol/ Bmax fmolJ 
Sebaceous Gland Kd,nM 109 protein Kd, nM mg protein 
H 5.25 7.03 7.30 9.20 
±OAI ± 1.71 ± 1.50 ±2.50 
B, 4.85 7.00 7.27 9.60 
±0.71 ± 1.10 ±1.20 ±2.30 
B, 6.56 5.27 8043 8.06 
±0.72 ±0.60 ±0.68 ± 1.19 
• Eilch ntue tJ the m~an ± SO of ~sum:ncs from thue independent Scatehiltd plots. 
There was nougnille;uu difference betw~en values of glands from h2.lry 3nd b.ald sc.alp. 
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Tabl. Ill. Displacement of ' H Labeled Ligands by Srcroids' 
% Displacemc lH 
---
I'HJDHT I' HJRI881 
-------
Source of Sebaceous Gl:and 
Steroid H H, B, H B. B, 
dihydrotestosterone (OHT) 74 69 75 79 78 76 
17a-methyltrienolone (R 1881) 77 78 69 84 86 79 
TestOSlerone 39 46 47 47 52 49 
4-androstencdiollC' 6 10 9 6 \I 12 
dehydrocpiandrosteronc 0 0 0 0 0 0 
promcgestonc 22 22 19 25 26 22 
rnoxestrol 28 28 32 33 31 35 
• E:lch VilJU~ IS the- aven.ge of threc mdepeode-OI bmdmg meuuremenn. 
was milder. and required soaking the scalp specimens in HDSS for 
approximately 1 h at 4°C prior to dissection without use of diges-
tive enzymes. The procedure yielded intact sebaceous glands. and 
permitted the srudy of androgen receptor proteins, which arc 
known to be thermolabile 112.211. and arc likely to be denatured if 
subjected ro long periods ot incubation at 37°C during the isolation 
procedure. 
The data in Table I dcmonstr.l.tcd highly specific binding in cyto-
sol of human sebaceous glands. although the number of binding 
sites was low for both DHT and mcthyltrienolone. DHT and 
I11cthyltrienolone apparently bind the same sites of the receptor. as 
they displace each other with equal efficiency (Table II I). Testoster-
one displaced approximately 45% of methyltrienolone and OHT, 
reflecting weaker affinity ofT to the receptor. 
The data in Table 1 show {hat H sebaceous glands had cytosol 
receptor with significantly less affinity and binding capacity for 
DHT and Illcthyltrienolone. These differences may reflect a state of 
hyperandrogenization in bald scalp and playa role in the pathogen-
esis of rhc balding process. It is nor clear whether any allosteric 
regulators or inhibitory protcins are prcsent to influence the recep-
tor activity. as found with estrogen receptors [22]. Similar studies of 
melanoma. benign nevi [23]. and lenrigo ma ligna 124] have also 
shown variations in steroid receptors when compared to normal 
tisslies. The prcsent da ra revealed no significant difference between 
sebaceous glands isolated from surgical and postmortem bald scalp 
specimens. 
In the evaluation of androgen binding, DHT is used as a ligand to 
ensure specificity [12]. while methyltrienolone has the advantage of 
not binding to the circulating sex binding proteins [25]' The relative 
affinities of the sebaceous gland cytosol receptor for the steroids 
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Figure 2. Distribution of protein-bound JH in a sucrose gr:adienr 2fter 
incubation of [3HJmcthyltrienolonc with cytosol of sebaceous gl2nds. De-
tails of thc procedure arc given in the text. Human hemoglobin (Hgb) :lnd 
cat21asc (COl) are used iIS markers. The peak of 'H corresponds to 7.SS. 
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~ Nuclei o( 'iCm.ccow glands were uol.l!ed (rom specimens ofh.llry scalp (H) and bald 
scalp (8) a5 described III Mdl(tldls /lnJ MrthoJs 
tcsted in this study were methyltrienolone = DHT > T > £2 = 
p> A, similar to that reponed by other authors [10.21]. On sucrose 
density gradient. tite receptor sedimented as 7 - 8S. The data clearly 
demonstrate the presence of a soluble receptor protein that specifi-
cally binds androgens. bur binds estrogen and progesterone analogs 
With much less affilllty (Table II). The data in Table III show speci-
ficity of the cytosol receptor protein for binding DHT, R 1881. and 
testosterone, and rdatively weak toinding for moxestrol and proges-
terone. Biologic effects of progestlJ1s and estrogens in the sebaceous 
gland have been studied previously [27.28]. Circulating levels of 
estrogen :md progesterone arc low in man [291 and neither steroid is 
considered a trophic hormone for the male sex accessory tissue. 
However, it is known that progestational agems can modify andro-
gen action by potentiation or inhibition. These mechanisms are not 
well understood, but binding of these hormones to the androgen 
fC'ceptOr (as revealed by data in Tables II and III) can influence the 
extent of androgen binding and. therefore, rhe rissue response to 
androgens. 
Table IV shows that the nuclei of sebaceolls glands isolated from 
bald scalp had 200/0 greater type I binding of hairy scalp. Kd's for 
type I binding werr: similar between Band H glands, and were 
smaller than Kd's for type II binding. Our data on type 1 and type II 
nuclear binding for androgen are in the same range as those for 
estrogen receptors reponed by Markaverich et al 116.17]. Those 
authors interpreted that type I nuclear binding sites represent the 
classical intracellular receptor which binds tlte hormone with high 
affinity (Kd - 1 nM), and translocates to the nucleus. Nuclear type 
11 s ite~ arc inducible , more abundant, and have lower binding affin-
ity. The exact role oftype II binding sites is still unclear; however, 
estrogen binding capacity, especially type II binding in uterine 
growth, is elevated under long-term chronic elevated hormone 
stimulation [16.17]. The increased nuclear androgen content of B 
glands may be imerpreted as reflecting the overandrogenic state. 
The/resent srudy of quantitative analysis of steroid receptors in 
isolate human sebaceous glands will be followed by a report of our 
study on receptor in human hair follicles. The scalp has more seba-
ceous glands than any other part of the body and these glands 3re 
androgen target organs. The dissociation constants and binding ca-
pacities of cytosol receptors we found are in the same range as 
reported for genital skin and other androgen-sensitive target tissues 
[25,30]. 
Androgenic response of a tissue depends on the presence of spe-
cific: .mdrogcn binding protein. In addition, enzymes of steroid me-
tabolism alter chemical stnlctu re of the steroids and also their hor-
monal pmcncy. In a recent study wc demonstrated the cOllversion of 
DHA into androstenedione, testosterone, and DHT in human seba-
ceous gland. and the greater enzymic activity of .1,s-3p-hydroxy-
ste roid dehydrogenase (3fJHSD) activity in sebaceous gland of bald 
scalp than in hairy scalp [31]. Taken together, greater 3PHSD activ-
ity and increased androgen binding capacity may provide a bio-
chellllcal explanation for the disease mechanism of androgenic alo-
pecia. Further such stud ies may provide new insigh t into the 
mechanism of skin diseases caused by hyperandrogenizarion. such as 
acne, hirsutism, and seborrhea. besides male pattern baldness. 
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